Tirzepatide Weight Loss Therapy in Hendersonville, Tennessee

What Is Tirzepatide?

Tirzepatide (brand name Zepbound for weight loss, Mounjaro for diabetes) represents the most advanced injectable weight loss therapy available today. It is a dual GIP/GLP-1 receptor agonist — meaning it activates two distinct hormone pathways simultaneously, producing a more powerful effect on appetite regulation and metabolism than GLP-1 agonists alone.

Available at Kanvas Wellness in Hendersonville, TN through our specialist team, tirzepatide offers patients from across Middle Tennessee access to cutting-edge weight management therapy.

How Tirzepatide Works: The Dual Action Advantage

Tirzepatide works through two complementary mechanisms:

• GLP-1 activation: Reduces appetite, slows gastric emptying, improves blood sugar regulation — the same mechanism as semaglutide
• GIP activation: Enhances insulin secretion, reduces fat accumulation, and may amplify the appetite-suppressing effects of GLP-1

This dual-action approach explains why clinical trials showed tirzepatide consistently outperforming semaglutide in terms of total weight loss, with patients losing an average of 20–22% of body weight at maximum doses.

Clinical Evidence for Tirzepatide

The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed 2,539 adults with obesity for 72 weeks. Results at the 15mg dose:

• Average weight loss: 22.5% of body weight
• 89% of participants lost at least 5% of body weight
• 56% lost at least 20% of body weight
• Significant improvements in cardiovascular risk factors

Tirzepatide vs. Semaglutide: Which Is Right for You?

Both medications are highly effective. Tirzepatide generally produces greater weight loss on average, but the best medication is the one that works for your specific health profile. Factors your Kanvas Wellness provider will consider include:

• Your current health status and any underlying conditions
• Previous response to GLP-1 medications
• Cost and insurance coverage considerations
• Tolerance of potential side effects
• Your specific metabolic profile

What to Expect With Tirzepatide Treatment

Tirzepatide is administered via once-weekly subcutaneous injection. Treatment begins at 2.5mg per week and is titrated up every 4 weeks (to 5mg, 7.5mg, 10mg, 12.5mg, and up to 15mg) to maximize efficacy while minimizing side effects.

Kanvas Wellness provides comprehensive support throughout your tirzepatide journey — from initial prescription through ongoing monitoring and protocol adjustments. We serve patients from Hendersonville, Gallatin, Goodlettsville, White House, Portland, and throughout the greater Nashville area.